RELEVANCE OF INTERSTRAND DNA CROSS-LINKING INDUCED BY ANTHRACYCLINES FOR THEIR BIOLOGICAL-ACTIVITY

被引:64
作者
SKLADANOWSKI, A [1 ]
KONOPA, J [1 ]
机构
[1] GDANSK TECH UNIV,DEPT PHARMACEUT TECHNOL & BIOCHEM,PL-80952 GDANSK,POLAND
关键词
ANTHRACYCLINES; INTERSTRAND DNA CROSS-LINKING; MECHANISM OF ACTION;
D O I
10.1016/0006-2952(94)90266-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The relevance of interstrand DNA crosslinking induced by anthracyclines for their cytotoxic action was studied in several biological systems with cells differing in sensitivity towards these compounds. It was done by establishing the correlation between DNA crosslinking and cytotoxic activity of anthracyclines. The study showed that there is a strong positive correlation between cytotoxic activity of anthracyclines and their DNA crosslinking potency in HeLa S-3 cells for a group of six Daunomycin derivatives (r = 0.97) as well as for all the studied 13 anthracyclines of divergent chemical structure (r = 0.95). Similar relationships between cytotoxic activity and DNA crosslinking ability was found for Adriamycin(R) and Daunomycin in three other cellular systems: (i) in LoVo and about 20-fold Adriamycin-resistant LoVo/DX human colon adenocarcinoma cells, (ii) CHO-K1 and its Adriamycin-hypersensitive mutant CHO-ADRS Chinese hamster ovary cells and (iii) HeLa S-3 cells sensitized about 3-fold to cytotoxic action of Adriamycin and Daunomycin by lowering intracellular glutathione content, to about 10% of normal level, by buthionine sulfoximine treatment. The presented results show that DNA crosslinking induced by anthracyclines may be responsible for the cytotoxic activity of these compounds.
引用
收藏
页码:2279 / 2287
页数:9
相关论文
共 28 条
[1]  
Arcamone F., 1989, GANN MONOGR CANC RES, V36, P81
[2]   DAUNORUBICIN AND DOXORUBICIN, ANTHRACYCLINE ANTIBIOTICS, A PHYSICOCHEMICAL AND BIOLOGICAL REVIEW [J].
AUBELSADRON, G ;
LONDOSGAGLIARDI, D .
BIOCHIMIE, 1984, 66 (05) :333-352
[3]  
BODLEY A, 1989, CANCER RES, V49, P5969
[4]  
CROOKE ST, 1978, MOL PHARMACOL, V14, P290
[5]  
DAVIES SM, 1989, CANCER RES, V49, P4526
[6]  
DUSRE L, 1989, CANCER RES, V49, P511
[7]  
GIANNI L, 1983, REV BIOCHEM TOXICOL, P1
[8]   ISOLATION AND CHARACTERIZATION OF A HUMAN-COLON ADENOCARCINOMA CELL-LINE RESISTANT TO DOXORUBICIN [J].
GRANDI, M ;
GERONI, C ;
GIULIANI, FC .
BRITISH JOURNAL OF CANCER, 1986, 54 (03) :515-518
[9]  
GRESH N, 1989, MOL PHARMACOL, V35, P251
[10]  
GUADIANO G, 1991, CHEM RES TOXICOL, V4, P2